Semin Reprod Med 2012; 30(04): 283-288
DOI: 10.1055/s-0032-1313907
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genome-Wide Analysis of Human Preimplantation Aneuploidy

Nathan R. Treff
1   Reproductive Medicine Associates of New Jersey, Morristown, New Jersey
2   Department of Obstetrics Gynecology and Reproductive Science, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey
3   Department of Genetics, Rutgers-The State University of New Jersey, Piscataway, New Jersey
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2012 (online)

Preview

Abstract

An exciting era in preimplantation genetic diagnosis (PGD) is emerging with the adaptation and development of new high throughput genome-wide methodologies for the evaluation of aneuploidy. In fact, many promising preclinical studies and clinical trials involving comprehensive chromosome screening (CCS) have renewed clinician interest in the use of PGD for aneuploidy screening as an embryo selection tool to improve the success of in vitro fertilization (IVF). This review will provide an overview of the basic underlying features and applications of the growing number of platforms and strategies for preimplantation genome-wide analysis of aneuploidy.